标题
Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-05-06
DOI
10.3389/fcimb.2020.00169
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of antibiotics that diminish disease in a murine model of enterohemorrhagic Escherichia coli infection
- (2020) Sabrina Mühlen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Commensal Enterobacteriaceae Protect against Salmonella Colonization through Oxygen Competition
- (2019) Yael Litvak et al. Cell Host & Microbe
- Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages
- (2019) Bi-o Kim et al. Viruses-Basel
- Prevention of EHEC infection by chitosan nano-structure coupled with synthetic recombinant antigen
- (2019) Jaleh Khanifar et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Shiga toxin-induced Haemolytic Uraemic Syndrome and the role of antibiotics
- (2019) Loukas Kakoullis et al. JOURNAL OF INFECTION
- Management of STEC Gastroenteritis: Is There a Role for Probiotics?
- (2019) Mario Giordano et al. International Journal of Environmental Research and Public Health
- Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae
- (2019) Sagi Sreerohini et al. APMIS
- Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity
- (2019) Jaleh Khanifar et al. Artificial Cells Nanomedicine and Biotechnology
- Shiga toxin 2eB‐transgenic lettuce vaccine is effective in protecting weaned piglets from edema disease caused by Shiga toxin‐producing Escherichia coli infection
- (2019) Takashi Hamabata et al. ANIMAL SCIENCE JOURNAL
- Development of an Arginine Anchored Nanoglobule with Retrograde Trafficking Inhibitor (Retro-2) for the Treatment of an Enterohemorrhagic Escherichia coli Outbreak
- (2019) Tasneem Gandhi et al. MOLECULAR PHARMACEUTICS
- Outcome of children with Shiga toxin–associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study
- (2019) Catherine Monet-Didailler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa
- (2019) David Ruano-Gallego et al. PLoS Pathogens
- Transcriptional and Translational Inhibitors Block SOS Response and Shiga Toxin Expression in Enterohemorrhagic Escherichia coli
- (2019) Michael Berger et al. Scientific Reports
- Inactivation of Escherichia coli O157:H7 and Salmonella on Fresh Herbs by Plant Essential Oils
- (2018) Jitendra Patel et al. Foodborne Pathogens and Disease
- Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity
- (2018) Adriana Albanese et al. VACCINE
- OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves
- (2018) Matias Fingermann et al. Human Vaccines & Immunotherapeutics
- Shiga toxin-glycosphingolipid interaction: Status quo of research with focus on primary human brain and kidney endothelial cells
- (2018) Nadine Legros et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects in vitro and in vivo
- (2018) Daniela Luz et al. Toxins
- Blood urea nitrogen to serum creatinine ratio is an accurate predictor of outcome in diarrhea-associated hemolytic uremic syndrome, a preliminary study
- (2017) Werner Keenswijk et al. EUROPEAN JOURNAL OF PEDIATRICS
- Use of Bacteriophages to Control Escherichia coli O157:H7 in Domestic Ruminants, Meat Products, and Fruits and Vegetables
- (2017) Lili Wang et al. Foodborne Pathogens and Disease
- A minireview on the in vitro and in vivo experiments with anti- Escherichia coli O157:H7 phages as potential biocontrol and phage therapy agents
- (2017) Salehe Sabouri et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Antimicrobial Effects of Quillaja saponaria Extract Against Escherichia coli O157:H7 and the Emerging Non-O157 Shiga Toxin-Producing E. coli
- (2017) Snigdha Sewlikar et al. JOURNAL OF FOOD SCIENCE
- Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice
- (2017) Ruqin Lin et al. MICROBIAL PATHOGENESIS
- Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model
- (2017) Rodney Moxley et al. Toxins
- Protection against Shiga Toxins
- (2017) Simona Kavaliauskiene et al. Toxins
- Oral Immunization with Recombinant Lactobacillus acidophilus Expressing espA-Tir-M Confers Protection against Enterohemorrhagic Escherichia coli O157:H7 Challenge in Mice
- (2017) Ruqin Lin et al. Frontiers in Microbiology
- Protection of Human Colon Cells from Shiga Toxin by Plant-based Recombinant Secretory IgA
- (2017) Katsuhiro Nakanishi et al. Scientific Reports
- Probiotic and enterohemorrhagic Escherichia coli: An effective strategy against a deadly enemy?
- (2016) Charlotte Cordonnier et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Inhibitory effects of grape seed extract on growth, quorum sensing, and virulence factors of CDC “top-six” non-O157 Shiga toxin producing E. coli
- (2016) L. Sheng et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Treatment ofin vitroenterohemorrhagicEscherichia coliinfection using phage and probiotics
- (2016) C. Dini et al. JOURNAL OF APPLIED MICROBIOLOGY
- Complement contributes to the pathogenesis of Shiga toxin–associated hemolytic uremic syndrome
- (2016) Diana Karpman et al. KIDNEY INTERNATIONAL
- Interactions between the microbiota and pathogenic bacteria in the gut
- (2016) Andreas J. Bäumler et al. NATURE
- Cellular effects of fluorodeoxyglucose: Global changes in the lipidome and alteration in intracellular transport
- (2016) Simona Kavaliauskiene et al. Oncotarget
- Vaccination with DNA Encoding Truncated Enterohemorrhagic Escherichia coli (EHEC) Factor for Adherence-1 Gene (efa-1′) Confers Protective Immunity to Mice Infected with E. coli O157:H7
- (2016) Roberto Riquelme-Neira et al. Frontiers in Cellular and Infection Microbiology
- Type Three Secretion System in Attaching and Effacing Pathogens
- (2016) Meztlli O. Gaytán et al. Frontiers in Cellular and Infection Microbiology
- Oral Delivery Systems for Encapsulated Bacteriophages Targeted at Escherichia coli O157:H7 in Feedlot Cattle
- (2016) K. STANFORD et al. JOURNAL OF FOOD PROTECTION
- Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit
- (2016) Petra Zadravec et al. PLoS One
- Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)
- (2016) Maria P. Mejías et al. Scientific Reports
- Retrograde Trafficking Inhibitor of Shiga Toxins Reduces Morbidity and Mortality of Mice Infected with Enterohemorrhagic Escherichia coli
- (2015) T. Secher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- AnIn VitroCombined Antibiotic-Antibody Treatment Eliminates Toxicity from Shiga Toxin-Producing Escherichia coli
- (2015) Craig Skinner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel actions of 2-deoxy-D-glucose: protection against Shiga toxins and changes in cellular lipids
- (2015) Simona Kavaliauskiene et al. BIOCHEMICAL JOURNAL
- Effect of Rifampicin and Gentamicin on Shiga Toxin 2 Expression Level and the SOS Response inEscherichia coliO104:H4
- (2015) Sukayna M. Fadlallah et al. Foodborne Pathogens and Disease
- Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement
- (2015) Lars Pape et al. MEDICINE
- Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7
- (2015) Kun Cai et al. Scientific Reports
- Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype
- (2015) Elias A. Rahal et al. Frontiers in Cellular and Infection Microbiology
- Development and Characterization of Recombinant Antibody Fragments That Recognize and Neutralize In Vitro Stx2 Toxin from Shiga Toxin-Producing Escherichia coli
- (2015) Daniela Luz et al. PLoS One
- Enhanced Virulence of the Escherichia coli O157:H7 Spinach-Associated Outbreak Strain in Two Animal Models Is Associated with Higher Levels of Stx2 Production after Induction with Ciprofloxacin
- (2014) T. Zangari et al. INFECTION AND IMMUNITY
- Peptides derived from phage display libraries as potential neutralizers of Shiga toxin-induced cytotoxicityin vitroandin vivo
- (2014) R.A. Bernedo-Navarro et al. JOURNAL OF APPLIED MICROBIOLOGY
- Protection from Hemolytic Uremic Syndrome by Eyedrop Vaccination with Modified Enterohemorrhagic E. coli Outer Membrane Vesicles
- (2014) Kyoung Sub Choi et al. PLoS One
- Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization
- (2014) B. Ahmed et al. VACCINE
- The Use of Direct-Fed Microbials to Reduce Shedding ofEscherichia coliO157 in Beef Cattle: A Systematic Review and Meta-analysis
- (2014) L. V. Wisener et al. Zoonoses and Public Health
- Effects of Subinhibitory Concentrations of Antimicrobial Agents on Escherichia coli O157:H7 Shiga Toxin Release and Role of the SOS Response
- (2013) Farah J. Nassar et al. Foodborne Pathogens and Disease
- A Single VHH-Based Toxin-Neutralizing Agent and an Effector Antibody Protect Mice against Challenge with Shiga Toxins 1 and 2
- (2013) Jacqueline M. Tremblay et al. INFECTION AND IMMUNITY
- Effect of coiled-coil peptides on the function of the type III secretion system-dependent activity of enterohemorragic Escherichia coli O157:H7 and Citrobacter rodentium
- (2013) Mariano Larzábal et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7
- (2013) Stefan A. Rund et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Effects of Lactobacillus kefiranofaciens M1 isolated from kefir grains on enterohemorrhagic Escherichia coli infection using mouse and intestinal cell models
- (2013) Y.P. Chen et al. JOURNAL OF DAIRY SCIENCE
- Inhibition of Cytotoxicity of Shiga Toxin of Escherichia coli O157:H7 on Vero Cells by Prosopis alba Griseb (Fabaceae) and Ziziphus mistol Griseb (Rhamnaceae) Extracts
- (2013) M. G. PELLARÍN et al. JOURNAL OF FOOD PROTECTION
- Immunization with a Chimera Consisting of the B Subunit of Shiga Toxin Type 2 and Brucella Lumazine Synthase Confers Total Protection against Shiga Toxins in Mice
- (2013) M. P. Mejias et al. JOURNAL OF IMMUNOLOGY
- N-Methyldihydroquinazolinone Derivatives of Retro-2 with Enhanced Efficacy against Shiga Toxin
- (2013) Romain Noel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab
- (2013) Y. Delmas et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Production of Hybrid-IgG/IgA Plantibodies with Neutralizing Activity against Shiga Toxin 1
- (2013) Katsuhiro Nakanishi et al. PLoS One
- Mouse in Vivo Neutralization of Escherichia coli Shiga Toxin 2 with Monoclonal Antibodies
- (2013) Luisa Cheng et al. Toxins
- Effects of Antibiotics on Shiga Toxin 2 Production and Bacteriophage Induction by Epidemic Escherichia coli O104:H4 Strain
- (2012) Martina Bielaszewska et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak
- (2012) Diana Corogeanu et al. BMC MICROBIOLOGY
- Protection by a Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Vaccine Expressing Shiga Toxin 2 B Subunit against Shiga Toxin-Producing Escherichia coli in Mice
- (2012) Jun Fujii et al. Clinical and Vaccine Immunology
- An Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Hemolytic Uremic Syndrome in Germany: Presentation and Short-term Outcome in Children
- (2012) S. Loos et al. CLINICAL INFECTIOUS DISEASES
- Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli Strains
- (2012) Luca Mogna et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Lactobacillus plantarum isolated from kefir protects vero cells from cytotoxicity by type-II shiga toxin from Escherichia coli O157:H7
- (2012) Emiliano Kakisu et al. JOURNAL OF DAIRY RESEARCH
- Evaluation of Lactic Acid as an Initial and Secondary Subprimal Intervention for Escherichia coli O157:H7, Non-O157 Shiga Toxin–Producing E. coli, and a Nonpathogenic E. coli Surrogate for E. coli O157:H7
- (2012) C. I. PITTMAN et al. JOURNAL OF FOOD PROTECTION
- Ellagitannin from Quercus infectoria eradicates intestinal colonization and prevents renal injuries in mice infected with Escherichia coli O157 : H7
- (2012) S. P. Voravuthikunchai et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Comparison of efficacies of bovine immune colostral antibody and each immunoglobulin class against verotoxin 2, flagellum and somatic cells of Escherichia coli O157:H7 in mice
- (2012) Tetsurou Seita et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice
- (2012) Aline Ferreira Oliveira et al. MICROBIOLOGY AND IMMUNOLOGY
- STEC-HUS, atypical HUS and TTP are all diseases of complement activation
- (2012) Marina Noris et al. Nature Reviews Nephrology
- Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry
- (2012) Jan T. Kielstein et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Genome Sequence of E. coli O104:H4 Leads to Rapid Development of a Targeted Antimicrobial Agent against This Emerging Pathogen
- (2012) Dean Scholl et al. PLoS One
- Antibodies to intimin and Escherichia coli-secreted proteins EspA and EspB in sera of Brazilian children with hemolytic uremic syndrome and healthy controls
- (2012) Mirian Guirro et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Mucosal priming of the murine immune system against enterohemorrhagic Escherichia coli O157:H7 using Lactococcus lactis expressing the type III secretion system protein EspB
- (2012) B. Ahmed et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study
- (2012) J. Menne et al. BMJ-British Medical Journal
- An Escherichia coli O157-Specific Engineered Pyocin Prevents and Ameliorates Infection by E. coli O157:H7 in an Animal Model of Diarrheal Disease
- (2011) Jennifer M. Ritchie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serological Response of Shiga Toxin-Producing Escherichia coli Type III Secreted Proteins in Sera from Vaccinated Rabbits, Naturally Infected Cattle, and Humans
- (2011) David J. Asper et al. Clinical and Vaccine Immunology
- Antimicrobial Activity of a Combination of Mume Fructus, Schizandrae Fructus, and Coptidis Rhizoma on Enterohemorrhagic Escherichia coli O26, O111, and O157 and Its Effect on Shiga Toxin Releases
- (2011) John Hwa Lee et al. Foodborne Pathogens and Disease
- Cross-Reactive Protection against Enterohemorrhagic Escherichia coli Infection by Enteropathogenic E. coli in a Mouse Model
- (2011) Carla Calderon Toledo et al. INFECTION AND IMMUNITY
- Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis
- (2011) M. Morigi et al. JOURNAL OF IMMUNOLOGY
- Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study
- (2011) Martina Bielaszewska et al. LANCET INFECTIOUS DISEASES
- B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate
- (2011) Cheng-song Wan et al. MICROBIOLOGY AND IMMUNOLOGY
- Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins
- (2011) Hong-ying Fan et al. MOLECULAR BIOLOGY REPORTS
- Bifidobacteria can protect from enteropathogenic infection through production of acetate
- (2011) Shinji Fukuda et al. NATURE
- Eculizumab in Severe Shiga-Toxin–Associated HUS
- (2011) Anne-Laure Lapeyraque et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide
- (2011) Deborah J. Stearns-Kurosawa et al. PEDIATRIC NEPHROLOGY
- A Glucosylceramide Synthase Inhibitor Protects Rats Against the Cytotoxic Effects of Shiga Toxin 2
- (2011) CLAUDIA SILBERSTEIN et al. PEDIATRIC RESEARCH
- Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice
- (2011) Jafar Amani et al. PLANT SCIENCE
- Prospective Genomic Characterization of the German Enterohemorrhagic Escherichia coli O104:H4 Outbreak by Rapid Next Generation Sequencing Technology
- (2011) Alexander Mellmann et al. PLoS One
- Inhibitors of Intravesicular Acidification Protect Against Shiga Toxin in a pH-Independent Manner
- (2011) Anne Berit Dyve Lingelem et al. TRAFFIC
- Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice
- (2011) Jiang Gu et al. VACCINE
- Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice
- (2011) Xiang Gao et al. VACCINE
- Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of Escherichia coli O157:H7-infected BALB/c mice
- (2011) Elias A Rahal et al. Annals of Clinical Microbiology and Antimicrobials
- Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge
- (2011) Ulrike Beate Mayr et al. Microbial Biotechnology
- Different Classes of Antibiotics Differentially Influence Shiga Toxin Production
- (2010) C. M. McGannon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo and Ex Vivo Evaluations of Bacteriophages e11/2 and e4/1c for Use in the Control of Escherichia coli O157:H7
- (2010) L. Rivas et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response
- (2010) Kun Cai et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Salmonella enterica Serovar Typhimurium Vaccine Strains Expressing a Nontoxic Shiga-Like Toxin 2 Derivative Induce Partial Protective Immunity to the Toxin Expressed by Enterohemorrhagic Escherichia coli
- (2010) R. L. G. Rojas et al. Clinical and Vaccine Immunology
- Identification of a novel linear epitope on EspA from enterohemorrhagic E. coli using a neutralizing and protective monoclonal antibody
- (2010) Shu Yu et al. CLINICAL IMMUNOLOGY
- ProbioticLactobacillus reuteriAmeliorates Disease Due to EnterohemorrhagicEscherichia coliin Germfree Mice
- (2010) Kathryn A. Eaton et al. INFECTION AND IMMUNITY
- Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice
- (2010) Elias A. Rahal et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial action of the American cranberry constituents; phenolics, anthocyanins, and organic acids, against Escherichia coli O157:H7
- (2010) Alison Lacombe et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Shiga Toxin 2–Specific but Not Shiga Toxin 1–Specific Human Monoclonal Antibody Protects Piglets Challenged with EnterohemorrhagicEscherichia coliProducing Shiga Toxin 1 and Shiga Toxin 2
- (2010) Kwang‐il Jeong et al. JOURNAL OF INFECTIOUS DISEASES
- Glycan-based high-affinity ligands for toxins and pathogen receptors
- (2010) Ashish A. Kulkarni et al. MEDICINAL RESEARCH REVIEWS
- Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7
- (2010) Jafar Amani et al. VACCINE
- Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7
- (2010) Krystle L. Mohawk et al. VACCINE
- Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection
- (2010) Kun Cai et al. VACCINE
- Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody, against Shiga-Like Toxin 2 in Healthy Adults and in Pediatric Patients Infected with Shiga-Like Toxin-Producing Escherichia coli
- (2009) E. L. Lopez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of Chimeric Anti-Shiga Toxin 1 and Anti-Shiga Toxin 2 Monoclonal Antibodies in Healthy Volunteers
- (2009) M. Bitzan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Engineered R-Type Pyocin Is a Highly Specific and Sensitive Bactericidal Agent for the Food-Borne Pathogen Escherichia coli O157:H7
- (2009) D. Scholl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A DNA Vaccine Encoding the Enterohemorragic Escherichia coli Shiga-Like Toxin 2 A2 and B Subunits Confers Protective Immunity to Shiga Toxin Challenge in the Murine Model
- (2009) L. V. Bentancor et al. Clinical and Vaccine Immunology
- Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections
- (2009) Antonio Serna et al. CURRENT OPINION IN GASTROENTEROLOGY
- Expression of EspA inLactococcus lactisNZ9000 and the detection of its immune effect in vivo and vitro
- (2009) Jingjing Luan et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- An Orally Applicable Shiga Toxin Neutralizer Functions in the Intestine To Inhibit the Intracellular Transport of the Toxin
- (2009) M. Watanabe-Takahashi et al. INFECTION AND IMMUNITY
- Host range and lytic capability of four bacteriophages against bovine and clinical human isolates of Shiga toxin-producingEscherichia coliO157:H7
- (2009) Y.D. Niu et al. JOURNAL OF APPLIED MICROBIOLOGY
- Screening and Analysis of Spices with Ability to Suppress Verocytotoxin Production by Escherichia coli O157
- (2009) Niro Takemasa et al. JOURNAL OF FOOD SCIENCE
- Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome
- (2009) Dorothea Orth et al. JOURNAL OF IMMUNOLOGY
- Gnotobiotic Piglet Infection Model for Evaluating the Safe Use of Antibiotics againstEscherichia coliO157:H7 Infection
- (2009) Quanshun Zhang et al. JOURNAL OF INFECTIOUS DISEASES
- Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: Implications for the vaccine development
- (2009) Yan Cheng et al. JOURNAL OF MICROBIOLOGY
- Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice
- (2009) Jiang Gu et al. MICROBES AND INFECTION
- Glycosphingolipid Requirements for Endosome-to-Golgi Transport of Shiga Toxin
- (2009) Hilde Raa et al. TRAFFIC
- Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins
- (2009) Jun Liu et al. VACCINE
- Immunogenicity of a novel Stx2B–Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection
- (2009) Xiang Gao et al. VACCINE
- Bacteriophages Reduce Experimental Contamination of Hard Surfaces, Tomato, Spinach, Broccoli, and Ground Beef by Escherichia coli O157:H7
- (2008) T. Abuladze et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Prevention and treatment of enterohemorrhagicEscherichia coliinfections in humans
- (2008) Dorothea Orth et al. Expert Review of Anti-Infective Therapy
- Subtype-Specific Suppression of Shiga Toxin 2 Released from Escherichia coli upon Exposure to Protein Synthesis Inhibitors
- (2008) M. G. Pedersen et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7
- (2008) Christine M. Carey et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice
- (2008) Shawn Babiuk et al. MICROBIAL PATHOGENESIS
- A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2
- (2008) Takao Tsuji et al. VACCINE
- Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant
- (2008) Angel Cataldi et al. VACCINE
- The immunogenicity of fusion protein linking the carboxyl terminus of the B subunit of Shiga toxin 2 to the B subunit of E. coli heat-labile enterotoxin
- (2007) Xue Qin Ran et al. VETERINARY MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search